Literature DB >> 28671332

Association between malnutrition and hyperhomocysteine in Alzheimer's disease patients and diet intervention of betaine.

Jianying Sun1, Shiling Wen1, Jing Zhou1, Shuling Ding1.   

Abstract

BACKGROUND: Alzheimer's disease (AD) is a neurodegenerative disease, which is associated with malnutrition and hyperhomocysteine. The current study aimed to analyze the relationship between malnutrition and hyperhomocysteine in AD patients, and effects of diet intervention with betaine on the disease.
METHODS: The nutritional statuses of the AD patients were assessed by short form mini nutritional assessment (MNA-SF). The levels of Hcy, tau hyperphosphorylation, synaptic proteins, blood inflammatory factors were measured by enzymatic cycling assay, Western blot and ELISA. The cognitive function was measured by AD assessment scale (ADAS-cog).
RESULTS: There was a significant difference in mental status between normal people and AD patients (P<.05). Overall, malnutrition was reported in a larger proportion of AD patients and high level of Hcy was closely associated with malnutrition. Betaine decreased the levels of phosphorylated tau, elevated PP2Ac activity and inhibited Aβ accumulation (P<.05). The levels of IL-lβ and TNF-α were significantly higher in the untreatment group while much lower in the intervention group (P<.05). After intervention of betaine treatment, the expression level of Hcy can be restored and betaine can effectively suppress inflammation as well as trigger an increase in memory-related proteins. ADAS-Cog suggested that significant improvement was found after the intervention of betaine.
CONCLUSIONS: AD was associated with both malnutrition and higher levels of Hcy. Betaine could restore Hcy expression to normal level in AD patient, which might ameliorate memory deficits.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  Alzheimer's disease; betaine; hyperhomocysteine; malnutrition

Mesh:

Substances:

Year:  2016        PMID: 28671332      PMCID: PMC6817125          DOI: 10.1002/jcla.22090

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  30 in total

Review 1.  Tau protein phosphatases in Alzheimer's disease: the leading role of PP2A.

Authors:  Ludovic Martin; Xenia Latypova; Cornelia M Wilson; Amandine Magnaudeix; Marie-Laure Perrin; Faraj Terro
Journal:  Ageing Res Rev       Date:  2012-07-06       Impact factor: 10.895

2.  Hyperhomocysteinemia is a risk factor for Alzheimer's disease in an Algerian population.

Authors:  Khaled Nazef; Malika Khelil; Hiba Chelouti; Ghouti Kacimi; Mohamed Bendini; Meriem Tazir; Soraya Belarbi; Mohamed El Hadi Cherifi; Bahia Djerdjouri
Journal:  Arch Med Res       Date:  2014-03-20       Impact factor: 2.235

3.  Studies on the protective effects of betaine against oxidative damage during experimentally induced restraint stress in Wistar albino rats.

Authors:  Balaraman Ganesan; Rangasamy Anandan; Pindath Thandayan Lakshmanan
Journal:  Cell Stress Chaperones       Date:  2011-06-30       Impact factor: 3.667

Review 4.  Nutritional approaches to modulate oxidative stress in Alzheimer's disease.

Authors:  C B Pocernich; M L Bader Lange; R Sultana; D A Butterfield
Journal:  Curr Alzheimer Res       Date:  2011-08       Impact factor: 3.498

5.  Higher homocysteine associated with thinner cortical gray matter in 803 participants from the Alzheimer's Disease Neuroimaging Initiative.

Authors:  Sarah K Madsen; Priya Rajagopalan; Shantanu H Joshi; Arthur W Toga; Paul M Thompson
Journal:  Neurobiol Aging       Date:  2014-08-30       Impact factor: 4.673

6.  Hyperhomocysteinemia in Alzheimer dementia patients and cognitive decline after 6 months follow-up period.

Authors:  Min-Chien Tu; Chi-Wei Huang; Nai-Ching Chen; Wen-Neng Chang; Chun-Chung Lui; Chih-Feng Chen; Ching Chen; Ya-Ling Wang; Yu-Ting Lin; Chiung-Chih Chang
Journal:  Acta Neurol Taiwan       Date:  2010-09

7.  Hyperhomocysteinemia in Alzheimer's disease: the hen and the egg?

Authors:  Melinda Farkas; Salla Keskitalo; Desiree E C Smith; Nadja Bain; Alexander Semmler; Benjamin Ineichen; Yvo Smulders; Henk Blom; Luka Kulic; Michael Linnebank
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

Review 8.  Betaine in human nutrition.

Authors:  Stuart A S Craig
Journal:  Am J Clin Nutr       Date:  2004-09       Impact factor: 7.045

Review 9.  Linking traumatic brain injury to chronic traumatic encephalopathy: identification of potential mechanisms leading to neurofibrillary tangle development.

Authors:  Brandon Peter Lucke-Wold; Ryan Coddington Turner; Aric Flint Logsdon; Julian Edwin Bailes; Jason Delwyn Huber; Charles Lee Rosen
Journal:  J Neurotrauma       Date:  2014-04-11       Impact factor: 5.269

10.  Nutritional status is associated with disease progression in very mild Alzheimer disease.

Authors:  Pierre-Jean Ousset; Fati Nourhashemi; Emma Reynish; Bruno Vellas
Journal:  Alzheimer Dis Assoc Disord       Date:  2008 Jan-Mar       Impact factor: 2.703

View more
  13 in total

Review 1.  NEU1-A Unique Therapeutic Target for Alzheimer's Disease.

Authors:  Aiza Khan; Consolato M Sergi
Journal:  Front Pharmacol       Date:  2022-06-29       Impact factor: 5.988

2.  Study of the value of homocysteine levels in predicting cognitive dysfunction in patients after acute carbon monoxide poisoning.

Authors:  Wei Ren; Xiao Shuai Zhou
Journal:  BMC Emerg Med       Date:  2022-07-19

3.  Ornipural® Mitigates Malathion-Induced Hepato-Renal Damage in Rats via Amelioration of Oxidative Stress Biomarkers, Restoration of Antioxidant Activity, and Attenuation of Inflammatory Response.

Authors:  Osama S El Okle; Hossam G Tohamy; Saed A Althobaiti; Mohamed Mohamed Soliman; Heba I Ghamry; Foad Farrag; Mustafa Shukry
Journal:  Antioxidants (Basel)       Date:  2022-04-11

4.  MicroRNA-132-3p alleviates neuron apoptosis and impairments of learning and memory abilities in Alzheimer's disease by downregulation of HNRNPU stabilized BACE1.

Authors:  Jie Qu; Xiaowei Xiong; Gulibaha Hujie; Jun Ren; Lihui Yan; Liqun Ma
Journal:  Cell Cycle       Date:  2021-09-29       Impact factor: 5.173

5.  Targeted Metabolomic Analysis in Alzheimer's Disease Plasma and Brain Tissue in Non-Hispanic Whites.

Authors:  Karel Kalecký; Dwight C German; Albert A Montillo; Teodoro Bottiglieri
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

Review 6.  Betaine in Inflammation: Mechanistic Aspects and Applications.

Authors:  Guangfu Zhao; Fang He; Chenlu Wu; Pan Li; Nengzhang Li; Jinping Deng; Guoqiang Zhu; Wenkai Ren; Yuanyi Peng
Journal:  Front Immunol       Date:  2018-05-24       Impact factor: 7.561

7.  Conventional and Unconventional Therapeutic Strategies for Sialidosis Type I.

Authors:  Rosario Mosca; Diantha van de Vlekkert; Yvan Campos; Leigh E Fremuth; Jaclyn Cadaoas; Vish Koppaka; Emil Kakkis; Cynthia Tifft; Camilo Toro; Simona Allievi; Cinzia Gellera; Laura Canafoglia; Gepke Visser; Ida Annunziata; Alessandra d'Azzo
Journal:  J Clin Med       Date:  2020-03-04       Impact factor: 4.241

8.  Standardized Lycium chinense fruit extract enhances attention and cognitive function in healthy young people by a double-blind, randomized, placebo-controlled, crossover trial.

Authors:  Sun-Yong Chung; Moonkyu Kang; Seong-Bin Hong; Hyunsu Bae; Seung-Hun Cho
Journal:  J Res Med Sci       Date:  2019-12-23       Impact factor: 1.852

Review 9.  Homocysteine and Age-Related Central Nervous System Diseases: Role of Inflammation.

Authors:  Amany Tawfik; Nehal M Elsherbiny; Yusra Zaidi; Pragya Rajpurohit
Journal:  Int J Mol Sci       Date:  2021-06-10       Impact factor: 5.923

10.  One-Carbon Metabolism in Alzheimer's Disease and Parkinson's Disease Brain Tissue.

Authors:  Karel Kalecký; Paula Ashcraft; Teodoro Bottiglieri
Journal:  Nutrients       Date:  2022-01-29       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.